Autotransfusion Device Market New Business Experts Ideas By Haemonetics, LivaNova, Redax, SARSTEDT, Braile Biomedica

The autotransfusion device market by product is segmented into intraoperative autotransfusion systems, postoperative autotransfusion systems, and dual-mode autotransfusion systems. The intraoperative autotransfusion systems segment held the largest market share in 2019 and is expected to dominate the market in 2027 as the system has an easy-to-use control panel, contains sequestration protocol for collecting platelet-rich plasma and platelet-deficient plasma, and can be operated in automatic or manual mode. Moreover, the same segment is anticipated to witness the fastest growth rate of 3.7% during the forecast period.

The scope of the autotransfusion device market includes type, application, end user, and region. Geographically, the autotransfusion device market is analyzed based on North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the autotransfusion device market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world.

Download sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006521/?openpr-10144

The autotransfusion device market was valued at US$ 936.64 million in 2019 and is projected to reach US$ 1,270.67 million by 2027; it is expected to grow at a CAGR of 4.0% from 2020 to 2027.

Some of the prominent players operating in autotransfusion device market are Medtronic, Fresenius SE & Co. KGaA, Teleflex Incorporated, BD, Zimmer Biomet, Braile Biomedica, Haemonetics Corporation, SARSTEDT AG and Co. KG, LivaNova PLC, and Redax S.p.A..

The market players are focused toward bringing new and innovative products and services to sustain their position in the market. For instance, in December, 2016, Fresenius Kabi and Terumo Cardiovascular Group introduced CAT Smart in the US Fresenius Kabi USA and Terumo Cardiovascular Group have signed an exclusive, five-year distribution agreement for CATSmart .The developments performed by the companies are helping the market to grow in the coming years.

The emergence of COVID-19 pandemic is estimated to have significant impact on the autotransfusion device market. Majority of the pharmaceutical companies around the globe are engaged in the development of vaccine for COVID-19. However, this shift of focus for research and development is anticipated to have negative impact on the other segments of the market. Also, the disruptions in supply chain caused due to shut down of global operations are also projected to have adverse impact on the market by certain extent.

Factors such as, involvement of rare blood groups, rising number of transplant procedures, and rising prevalence of chronic diseases are contributing to the growth of the market. However, risks associated with autotransfusion are likely to pose a negative impact on the market growth. On the other hand, need for reinfusion of blood is likely to have a positive impact on the growth of the global autotransfusion device market in the coming years.

The autotransfusion process involves the reinfusion of the patient's blood collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, such as joint replacement, spinal surgeries, and cardiac surgery require autotransfusion. It helps reduce the risk of infection, and eliminates the problems and complications associated with the banking and administration of homologous donor blood. It also prevents transmission of transfusion-related blood-borne diseases in patients.

The Report Segments the Global Autotransfusion Device Market as Follows:

Global Autotransfusion Device Market – By Type

Product
Intraoperative Autotransfusion Systems
Postoperative Autotransfusion Systems
Dual-Mode Autotransfusion Systems
Accessories

Global Autotransfusion Device Market – By Application

Cardiac Surgeries
Orthopaedic Surgeries
Organ Transplantation
Trauma Procedures
Others

Global Autotransfusion Device Market – By End User

Hospitals
Specialty Clinics
Ambulatory Surgery Centers

Buy this Report @ https://www.theinsightpartners.com/buy/TIPRE00006521/?openpr-10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.